| Peer-Reviewed

A Systematic Review and Meta-analysis of the Efficacy of Medical Masks and N95 Respirators for Protection Against Respiratory Infectious Diseases

Received: 12 May 2022    Accepted: 13 June 2022    Published: 16 June 2022
Views:       Downloads:
Abstract

To evaluate the efficacy of N95 respirators and medical masks for protection against respiratory infectious diseases, including COVID-19. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) and observational studies evaluating the use of N95 respirators and medical masks for protection against respiratory infectious diseases. We retrieved relevant articles published from January 1994 to January 2020 by searching the PubMed, EMBASE, Cochrane CENTRAL, and Web of Science databases. The study quality was evaluated using the Cochrane Risk of Bias tool with RevMan 5.3 software. Eleven RCTs adjusted for clustering were included in the meta-analysis. Compared with the control group, N95 respirators or medical masks conferred significant protection against respiratory infectious diseases (odds ratio (OR) = 0.20; 95% CI: 0.08–0.51). Compared to medical masks, N95 respirators conferred significant protection against respiratory infectious diseases (OR = 0.75; 95% confidence interval (CI): 0.57–0.99). Meta-analysis of 10 observational studies adjusting for clustering also suggested that N95 respirators and medical masks are effective for protection against respiratory infectious diseases (OR = 0.30; 95% CI: 0.15–0.63). Given the body of evidence through a systematic review and meta-analyses, our findings supported the use of N95 respirators or medical masks has a significantly greater protective effect against respiratory infectious diseases among medical workers compared with those who did not use these types of PPE. However, only one case report showed the effectiveness of medical masks for preventing COVID-19. Although medical masks and N95 respirators may confer significant protection against respiratory infectious diseases, there is insufficient evidence to conclude that these types of personal protective equipment offer similar protection against COVID-19. Moreover, in the absence of sufficient resources during an epidemic, medical masks and N95 respirators should be reserved for high-risk, aerosol-generating producing procedures.

Published in Science Journal of Public Health (Volume 10, Issue 3)
DOI 10.11648/j.sjph.20221003.16
Page(s) 142-157
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Respiratory Infectious Diseases, COVID-19, Medical Masks, N95 Respirators, Meta-analysis

References
[1] Shi T, McAllister DA, O'Brien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet 2017, 390 (10098): 946-958.
[2] Huang C, Wang Y, Li X,, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395 (10223): 497-506.
[3] The Lancet. COVID-19: protecting health-care workers. Lancet 2020, 395 (10228): 922.
[4] Ali Y, Alradhawi M, Shubber N, et al. Personal protective equipment in the response to the SARS-CoV-2 outbreak - A letter to the editor on "World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)" (Int J Surg 2020; 76: 71-6). Int J Surg 2020, 78: 66-67.
[5] MacIntyre CR, Chughtai AA, Rahman B, et al. The efficacy of medical masks and respirators against respiratory infection in healthcare workers. Influenza Other Respir Viruses 2017, 11 (6): 511-517.
[6] Liang M, Gao L, Cheng C, et al. Efficacy of face mask in preventing respiratory virus transmission: A systematic review and meta-analysis. Travel Med Infect Dis 2020, 36: 101751.
[7] Michaelis R, Tang V, Wagner JL, et al. Cochrane systematic review and meta-analysis of the impact of psychological treatments for people with epilepsy on health-related quality of life. Epilepsia 2018, 59 (2): 315-332.
[8] Seto WH, Tsang D, Yung RW,, et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003, 361 (9368): 1519-20.
[9] Al-Asmary S, Al-Shehri AS, Abou-Zeid A, et al. Acute respiratory tract infections among Hajj medical mission personnel, Saudi Arabia. Int J Infect Dis 2007, 11 (3): 268-72.
[10] Ng TC, Lee N, Hui SC, et al. Preventing healthcare workers from acquiring influenza. Infect Control Hosp Epidemiol 2009; 30 (3): 292-5.
[11] Yang P, Seale H, MacIntyre CR, Zhang H, et al. Mask-wearing and respiratory infection in healthcare workers in Beijing, China. Braz J Infect Dis 2011, 15 (2): 102-8.
[12] MacIntyre CR, Wang Q, Cauchemez S, et al. A cluster randomized clinical trial comparing fit-tested and non-fit-tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers. Influenza Other Respir Viruses 2011, 5 (3): 170-9.
[13] MacIntyre CR, Wang Q, Rahman B, et al. Efficacy of face masks and respirators in preventing upper respiratory tract bacterial colonization and co-infection in hospital healthcare workers. Prev Med 2014, 62: 1-7.
[14] MacIntyre CR, Seale H, Dung TC, et al. A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ Open 2015, 5 (4): e006577.
[15] Loeb M, Dafoe N, Mahony J, et al. Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA 2009, 302 (17): 1865-71.
[16] MacIntyre CR, Cauchemez S, Dwyer DE, et al. Face mask use and control of respiratory virus transmission in households. Emerg Infect Dis 2009, 15 (2): 233-41.
[17] MacIntyre CR, Wang Q, Seale H, et al. A randomized clinical trial of three options for N95 respirators and medical masks in health workers. Am J Respir Crit Care Med 2013, 187 (9): 960-6.
[18] Radonovich LJ Jr, Simberkoff MS, Bessesen MT, et al. N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial. JAMA 2019, 322 (9): 824-833.
[19] Scales DC, Green K, Chan AK, et al. Illness in intensive care staff after brief exposure to severe acute respiratory syndrome. Emerg Infect Dis 2003, 9 (10): 1205-10.
[20] Teleman MD, Boudville IC, Heng BH, et al. Factors associated with transmission of severe acute respiratory syndrome among health-care workers in Singapore. Epidemiol Infect 2004, 132 (5): 797-803.
[21] Yin WW, Gao LD, Lin WS, et al. [Effectiveness of personal protective measures in prevention of nosocomial transmission of severe acute respiratory syndrome]. Zhonghua Liu Xing Bing Xue Za Zhi 2004, 25 (1): 18-22.
[22] Nishiyama A, Wakasugi N, Kirikae T, et al. Risk factors for SARS infection within hospitals in Hanoi, Vietnam. Jpn J Infect Dis. 2008, 61 (5): 388-90.
[23] Wilder-Smith A, Teleman MD, Heng BH, et al. Asymptomatic SARS coronavirus infection among healthcare workers, Singapore. Emerg Infect Dis 2005, 11 (7): 1142-5.
[24] Nanda A, Hung I, Kwong A, et al. Efficacy of surgical masks or cloth masks in the prevention of viral transmission: Systematic review, meta-analysis, and proposal for future trial. J Evid Based Med 2021, 14 (2): 97-111.
[25] Wang ME, Ratner AJ. Clinical Guideline Highlights for the Hospitalist: Diagnosis and Management of Measles. J Hosp Med 2020, 15 (1): 47-48.
[26] Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020, 323 (11): 1061-1069.
[27] Mahmood SU, Crimbly F, Khan S, et al. Strategies for Rational Use of Personal Protective Equipment (PPE) Among Healthcare Providers During the COVID-19 Crisis. Cureus 2020, 12 (5): e8248.
[28] Science M, Bolotin S, Silverman M, et al. SARS-CoV-2 antibodies in Ontario health care workers during and after the first wave of the pandemic: a cohort study. CMAJ Open 2021, 9 (4): E929-E939.
[29] Bartoszko JJ, Farooqi MAM, Alhazzani W, et al. Medical masks vs N95 respirators for preventing COVID-19 in healthcare workers: A systematic review and meta-analysis of randomized trials. Influenza Other Respir Viruses 2020, 14 (4): 365-373.
[30] Kobayashi LM, Marins BR, Costa PCDS, et al. Extended use or reuse of N95 respirators during COVID-19 pandemic: An overview of national regulatory authority recommendations. Infect Control Hosp Epidemiol 2020, 41 (11): 1364-1366.
[31] Ng K, Poon BH, Kiat Puar TH, et al. COVID-19 and the Risk to Health Care Workers: A Case Report. Ann Intern Med 2020, 172 (11): 766-767.
Cite This Article
  • APA Style

    Gaohong Wu, Qingyang Ji, Huiwen Huang, Xueping Zhu. (2022). A Systematic Review and Meta-analysis of the Efficacy of Medical Masks and N95 Respirators for Protection Against Respiratory Infectious Diseases. Science Journal of Public Health, 10(3), 142-157. https://doi.org/10.11648/j.sjph.20221003.16

    Copy | Download

    ACS Style

    Gaohong Wu; Qingyang Ji; Huiwen Huang; Xueping Zhu. A Systematic Review and Meta-analysis of the Efficacy of Medical Masks and N95 Respirators for Protection Against Respiratory Infectious Diseases. Sci. J. Public Health 2022, 10(3), 142-157. doi: 10.11648/j.sjph.20221003.16

    Copy | Download

    AMA Style

    Gaohong Wu, Qingyang Ji, Huiwen Huang, Xueping Zhu. A Systematic Review and Meta-analysis of the Efficacy of Medical Masks and N95 Respirators for Protection Against Respiratory Infectious Diseases. Sci J Public Health. 2022;10(3):142-157. doi: 10.11648/j.sjph.20221003.16

    Copy | Download

  • @article{10.11648/j.sjph.20221003.16,
      author = {Gaohong Wu and Qingyang Ji and Huiwen Huang and Xueping Zhu},
      title = {A Systematic Review and Meta-analysis of the Efficacy of Medical Masks and N95 Respirators for Protection Against Respiratory Infectious Diseases},
      journal = {Science Journal of Public Health},
      volume = {10},
      number = {3},
      pages = {142-157},
      doi = {10.11648/j.sjph.20221003.16},
      url = {https://doi.org/10.11648/j.sjph.20221003.16},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjph.20221003.16},
      abstract = {To evaluate the efficacy of N95 respirators and medical masks for protection against respiratory infectious diseases, including COVID-19. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) and observational studies evaluating the use of N95 respirators and medical masks for protection against respiratory infectious diseases. We retrieved relevant articles published from January 1994 to January 2020 by searching the PubMed, EMBASE, Cochrane CENTRAL, and Web of Science databases. The study quality was evaluated using the Cochrane Risk of Bias tool with RevMan 5.3 software. Eleven RCTs adjusted for clustering were included in the meta-analysis. Compared with the control group, N95 respirators or medical masks conferred significant protection against respiratory infectious diseases (odds ratio (OR) = 0.20; 95% CI: 0.08–0.51). Compared to medical masks, N95 respirators conferred significant protection against respiratory infectious diseases (OR = 0.75; 95% confidence interval (CI): 0.57–0.99). Meta-analysis of 10 observational studies adjusting for clustering also suggested that N95 respirators and medical masks are effective for protection against respiratory infectious diseases (OR = 0.30; 95% CI: 0.15–0.63). Given the body of evidence through a systematic review and meta-analyses, our findings supported the use of N95 respirators or medical masks has a significantly greater protective effect against respiratory infectious diseases among medical workers compared with those who did not use these types of PPE. However, only one case report showed the effectiveness of medical masks for preventing COVID-19. Although medical masks and N95 respirators may confer significant protection against respiratory infectious diseases, there is insufficient evidence to conclude that these types of personal protective equipment offer similar protection against COVID-19. Moreover, in the absence of sufficient resources during an epidemic, medical masks and N95 respirators should be reserved for high-risk, aerosol-generating producing procedures.},
     year = {2022}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - A Systematic Review and Meta-analysis of the Efficacy of Medical Masks and N95 Respirators for Protection Against Respiratory Infectious Diseases
    AU  - Gaohong Wu
    AU  - Qingyang Ji
    AU  - Huiwen Huang
    AU  - Xueping Zhu
    Y1  - 2022/06/16
    PY  - 2022
    N1  - https://doi.org/10.11648/j.sjph.20221003.16
    DO  - 10.11648/j.sjph.20221003.16
    T2  - Science Journal of Public Health
    JF  - Science Journal of Public Health
    JO  - Science Journal of Public Health
    SP  - 142
    EP  - 157
    PB  - Science Publishing Group
    SN  - 2328-7950
    UR  - https://doi.org/10.11648/j.sjph.20221003.16
    AB  - To evaluate the efficacy of N95 respirators and medical masks for protection against respiratory infectious diseases, including COVID-19. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) and observational studies evaluating the use of N95 respirators and medical masks for protection against respiratory infectious diseases. We retrieved relevant articles published from January 1994 to January 2020 by searching the PubMed, EMBASE, Cochrane CENTRAL, and Web of Science databases. The study quality was evaluated using the Cochrane Risk of Bias tool with RevMan 5.3 software. Eleven RCTs adjusted for clustering were included in the meta-analysis. Compared with the control group, N95 respirators or medical masks conferred significant protection against respiratory infectious diseases (odds ratio (OR) = 0.20; 95% CI: 0.08–0.51). Compared to medical masks, N95 respirators conferred significant protection against respiratory infectious diseases (OR = 0.75; 95% confidence interval (CI): 0.57–0.99). Meta-analysis of 10 observational studies adjusting for clustering also suggested that N95 respirators and medical masks are effective for protection against respiratory infectious diseases (OR = 0.30; 95% CI: 0.15–0.63). Given the body of evidence through a systematic review and meta-analyses, our findings supported the use of N95 respirators or medical masks has a significantly greater protective effect against respiratory infectious diseases among medical workers compared with those who did not use these types of PPE. However, only one case report showed the effectiveness of medical masks for preventing COVID-19. Although medical masks and N95 respirators may confer significant protection against respiratory infectious diseases, there is insufficient evidence to conclude that these types of personal protective equipment offer similar protection against COVID-19. Moreover, in the absence of sufficient resources during an epidemic, medical masks and N95 respirators should be reserved for high-risk, aerosol-generating producing procedures.
    VL  - 10
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Department of Neonatology, Zhuhai Women and Children’s Hospital, Zhuhai, China

  • Department of Neonatology, Zhuhai Women and Children’s Hospital, Zhuhai, China

  • Department of Neonatology, Zhuhai Women and Children’s Hospital, Zhuhai, China

  • Department of Neonatology, Children’s Hospital of Soochow University, Suzhou, China

  • Sections